←Back to Expert Scholars
Translational Medicine / 转化医学LKB1-AMPK Pathway, Lung Cancer
Reuben Shaw
PhD
🏢Salk Institute for Biological Studies🌐USA
Director, Salk Cancer Center
90
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Reuben Shaw has defined the role of the LKB1-AMPK axis in tumor suppression, particularly in non-small cell lung cancer. His laboratory elucidated how loss of LKB1 deregulates metabolism and growth signaling. He directs the Salk Cancer Center and drives translational cancer metabolism research.
Share:
🧪Research Fields 研究领域
LKB1
AMPK
lung cancer
metabolic signaling
autophagy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Reuben Shaw 的研究动态
Follow Reuben Shaw's research updates
留下邮箱，当我们发布与 Reuben Shaw（Salk Institute for Biological Studies）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment